Drug Trial Radar · NCT03030105
Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Oct 16, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
38
Actual
Start
Jan 2017
Primary completion
May 2017
Study completion Jun 2017
Sponsor
- Lead sponsor
- Tetra Discovery PartnersIndustry
- Sponsor type
- Industry
- First posted
- Jan 24, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, randomized, double-blind, placebo-controlled, 6-period crossover study to evaluate the effects of BPN14770 10 mg and 50 mg in reversing scopolamine-induced cognitive impairment in healthy volunteers. A positive control, donepezil 10 mg, will be included, and additivity of BPN14770 50 mg to donepezil 10 mg in reversing scopolamine effects will also be evaluated.
Conditions
- Alzheimer Disease
Interventions
BPN14770Drug
investigational drug
BPN14770 placeboDrug
placebo
DonepezilDrug
comparator
Donepezil placeboDrug
placebo
Scopolamine 0.6 MG/MLDrug
cognition impairment
Scopolamine placeboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Groton Maze Learning Test (GMLT)Time frame: 2 hours post-scopolamine s.c. injection
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON Early Phase Services, LLC
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.